NDC 42291-0345-01: Imipramine Hydrochloride 10 mg Tablet, Film Coated, Bottle of 100
This is a package of 100 tablets of Imipramine Hydrochloride 10 mg Tablet, Film Coated from AvKARE, no longer marketed, no longer in the FDA NDC Directory. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 42291-345-01 alone.
- Record
- FDA NDC Directory package listing · Human prescription drug
- Code segments
- 42291 labeler · 345 product · 01 package
- Billing quantity
- 100 EA per package
- Barcode (UPC-A, from the NDC)
- 3 4229134501 0
- FDA record last changed
- Mar 13, 2024
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
- GSN (GCN sequence number): 046068
- GCN: 16541
- HICL (First Databank): 001641
- AHFS class code: 28:16.04.28
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
- It treats depression. The Imipramine Hydrochloride tablets are also used as temporary add-on treatment for bedwetting in kids 6 and older, once other causes are ruled out.
- For depression, it can take one to three weeks to feel the full effect. Keep taking it as prescribed even if you don't feel better right away, and talk to your prescriber if you ha...
- Please don't stop on your own. Stopping suddenly after long-term use can cause nausea, headache, and malaise. Your prescriber will lower the dose gradually.
- Dry mouth, blurred vision, constipation, drowsiness, and dizziness are common. Call your doctor for fast or irregular heartbeat, seizures, severe confusion, eye pain, or any suicid...
Patient education
Drug interactions
Supplement & herbal interactions
Imipramine may be associated with lower levels of 3 nutrients — worth a chat with your pharmacist, not a cause for alarm.
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 42291-0345-01 You're viewing this Main listing | 100 TABLET, FILM COATED in 1 BOTTLE | 2015-12-09 | — | Discontinued by firm |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Imipramine Hydrochloride 10 mg 64380-0169-01 | Strides | 100 tablets | $0.079 | AB | Availability likely | — |
| Imipramine Hydrochloride 10 mg 69315-0133-01 | Leading | 100 tablets | $0.079 | AB | Availability likely | — |
| Imipramine Hydrochloride 10 mg 69584-0425-10 | Oxford | 100 tablets | $0.079 | AB | Availability likely | — |
| Imipramine Hydrochloride 10 mg 71205-0804-30 | Proficient | 30 tablets | — | AB | FDA listed | — |
| Imipramine Hydrochloride 10 mg 71335-3106-01 | Bryant | 30 tablets | — | AB | FDA listed | — |
| Imipramine Hydrochloride 10 mg 72789-0240-01 | PD-Rx | 100 tablets | — | AB | FDA listed | — |
| Imipramine hydrochloride 10 mg 80425-0294-01 | Advanced | 30 tablets | — | AB | FDA listed | — |
| Imipramine Hydrochloride 10 mg 82804-0956-00 | Proficient | 100 tablets | — | AB | FDA listed | — |
| Imipramine Hydrochloride 10 mgthis 42291-0345-01 | AvKARE | 100 tablets | — | AB | Discontinued | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Imipramine inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from AvKARE labeler code 42291
- Glipizide and Metformin Hydrochloride 5 mg; 500 mg Tablet, Film Coated NDC 42291-306-01
- Hydroxyurea 500 mg Capsule NDC 42291-321-01
- guanfacine 1 mg Tablet, Extended Release NDC 42291-324-01
- guanfacine 2 mg Tablet, Extended Release NDC 42291-325-01
- guanfacine 3 mg Tablet, Extended Release NDC 42291-326-01
- guanfacine 4 mg Tablet, Extended Release NDC 42291-327-01
- Lamotrigine 25 mg Tablet NDC 42291-366-01
- Lamotrigine 100 mg Tablet NDC 42291-367-01
- Lamotrigine 150 mg Tablet NDC 42291-368-50
- Lamotrigine 200 mg Tablet NDC 42291-369-50
- Letrozole 2.5 mg Tablet, Film Coated NDC 42291-374-30
- Lidocaine 4 g/100g Cream NDC 42291-399-30
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
Full prescribing information FDA SPL
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | — Not published for this NDC No structured label is linked to this listing in DailyMed/openFDA. |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | ✓ Available |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |